Press Releases

Showing 246-261 of 261


2011

February

February 15

Abbott to Present at RBC Capital Markets' Healthcare Conference

February 7

Abbott Introduces Biothreat Assay for PLEX-ID™ System

February 7

Abbott’s Ibis Technology Identified Fatal Disease Organism in Afghanistan
 

January

January 31

Abbott's TREK® Coronary Balloon System Now Available in the United States and Japan

January 26

Abbott Reports Double-Digit Sales and Ongoing Earnings Growth in Fourth Quarter; Issues Ongoing Earnings Outlook for 2011

January 26

FDA Advisory Committee Votes Favorably on Expanding the Indication for Abbott's Carotid Stent System to Include Patients at Standard Surgical Risk

January 25

New Abbott Vitamin D Test Available for Use in the European Union

January 10

Abbott Receives CE Mark Approval for World's First  Drug Eluting Bioresorbable Vascular Scaffold for Treatment of Coronary Artery Disease

January 7

Partners In Health, Abbott and the Abbott Fund Unite to Combat Severe Childhood Malnutrition in Haiti

January 3

Abbott Hosts Conference Call for Fourth-Quarter and Full-Year 2010 Earnings

2010

September

September 23

Abbott's XIENCE V® Shows Outstanding Two-Year Clinical Results Versus TAXUS® in Key Safety and Efficacy Measures in SPIRIT IV Trial
 

May

May 25

Abbott's Investigational MitraClip® System Demonstrates Strong Safety Results and Improved Clinical Outcomes for Common Causes of Leaky Heart Valves
 

March

March 14

New Data Demonstrates Abbott's Investigational MitraClip® System Has Potential to be a Valuable Treatment Option for Patients with Mitral Regurgitation, the Most Common Heart Valve Condition

2009

November

November 2

Abbott's XIENCE PRIME™ and XIENCE V® Receive Indications in Europe for Treatment of Patients with Diabetes
 

August

August 31

Abbott Launches Next-Generation XIENCE PRIME™ Drug Eluting Stent in International Markets
 

June

June 12

Abbott Announces Launch of Next-Generation Embolic Protection System